Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · IEX Real-Time Price · USD
1.490
0.00 (0.00%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Dyadic International Revenue
In the year 2023, Dyadic International had annual revenue of $2.90M, a decrease of -1.07%. Revenue in the quarter ending December 31, 2023 was $686.54K, a -7.69% decrease year-over-year.
Revenue (ttm)
$2.90M
Revenue Growth
-1.07%
P/S Ratio
14.89
Revenue / Employee
$414,115
Employees
7
Market Cap
43.56M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.90M | -31.50K | -1.07% |
Dec 31, 2022 | 2.93M | 526.47K | 21.90% |
Dec 31, 2021 | 2.40M | 801.91K | 50.06% |
Dec 31, 2020 | 1.60M | -79.16K | -4.71% |
Dec 31, 2019 | 1.68M | 385.63K | 29.77% |
Dec 31, 2018 | 1.30M | 537.03K | 70.81% |
Dec 31, 2017 | 758.42K | 165.53K | 27.92% |
Dec 31, 2016 | 592.89K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.28B |
Rockwell Medical | 83.61M |
Cytosorbents | 36.35M |
Aadi Bioscience | 24.35M |
DarioHealth | 20.35M |
Milestone Scientific | 9.83M |
Bolt Biotherapeutics | 7.88M |
Matinas BioPharma Holdings | 1.10M |
DYAI News
- 4 weeks ago - Dyadic Reports 2023 Full Year Results and Recent Company Progress - GlobeNewsWire
- 4 weeks ago - Dyadic Announces Change in Board and Management Leadership Roles - GlobeNewsWire
- 4 weeks ago - Dyadic to Attend Industry Events in April - GlobeNewsWire
- 4 weeks ago - Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications - GlobeNewsWire
- 5 weeks ago - Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California - GlobeNewsWire
- 6 weeks ago - Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024 - GlobeNewsWire
- 6 weeks ago - CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization - GlobeNewsWire
- 6 weeks ago - Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization - GlobeNewsWire